van Beuge MM - Search Results

1

Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease.

Ten Dam EJ, van Beuge MM, Bank RA, Werker PM. Ten Dam EJ, et al. Among authors: van beuge mm. J Cell Commun Signal. 2016 Mar;10(1):33-40. doi: 10.1007/s12079-015-0312-8. Epub 2015 Dec 3. J Cell Commun Signal. 2016. PMID: 26635199 Free PMC article.

2

Wnt pathway in Dupuytren disease: connecting profibrotic signals.

van Beuge MM, Ten Dam EJ, Werker PM, Bank RA. van Beuge MM, et al. Transl Res. 2015 Dec;166(6):762-771.e3. doi: 10.1016/j.trsl.2015.09.006. Epub 2015 Sep 25. Transl Res. 2015. PMID: 26470681

3

Matrix and cell phenotype differences in Dupuytren's disease.

van Beuge MM, Ten Dam EJ, Werker PM, Bank RA. van Beuge MM, et al. Fibrogenesis Tissue Repair. 2016 Jun 29;9:9. doi: 10.1186/s13069-016-0046-0. eCollection 2016. Fibrogenesis Tissue Repair. 2016. PMID: 27366208 Free PMC article.

4

YAP1 Is a Driver of Myofibroblast Differentiation in Normal and Diseased Fibroblasts.

Piersma B, de Rond S, Werker PM, Boo S, Hinz B, van Beuge MM, Bank RA. Piersma B, et al. Among authors: van beuge mm. Am J Pathol. 2015 Dec;185(12):3326-37. doi: 10.1016/j.ajpath.2015.08.011. Epub 2015 Oct 10. Am J Pathol. 2015. PMID: 26458763 Free article.

5

Microsphere-Based Rapamycin Delivery, Systemic Versus Local Administration in a Rat Model of Renal Ischemia/Reperfusion Injury.

Zandstra J, van Beuge MM, Zuidema J, Petersen AH, Staal M, Duque LF, Rodriguez S, Lathuile AA, Veldhuis GJ, Steendam R, Bank RA, Popa ER. Zandstra J, et al. Among authors: van beuge mm. Pharm Res. 2015 Oct;32(10):3238-47. doi: 10.1007/s11095-015-1700-8. Epub 2015 May 9. Pharm Res. 2015. PMID: 25957099 Free PMC article.

6

Microsphere size influences the foreign body reaction.

Zandstra J, Hiemstra C, Petersen AH, Zuidema J, van Beuge MM, Rodriguez S, Lathuile AA, Veldhuis GJ, Steendam R, Bank RA, Popa ER. Zandstra J, et al. Among authors: van beuge mm. Eur Cell Mater. 2014 Oct 28;28:335-47. doi: 10.22203/ecm.v028a23. Eur Cell Mater. 2014. PMID: 25350249 Free article.

7

Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.

van Beuge MM, Prakash J, Lacombe M, Post E, Reker-Smit C, Beljaars L, Poelstra K. van Beuge MM, et al. Pharm Res. 2011 Aug;28(8):2045-54. doi: 10.1007/s11095-011-0430-9. Epub 2011 Mar 26. Pharm Res. 2011. PMID: 21442374 Free PMC article.

8

Specific delivery of kinase inhibitors in nonmalignant and malignant diseases.

van Beuge MM, Poelstra K, Prakash J. van Beuge MM, et al. Expert Opin Drug Deliv. 2012 Jan;9(1):59-70. doi: 10.1517/17425247.2012.638625. Epub 2011 Nov 23. Expert Opin Drug Deliv. 2012. PMID: 22111941 Review.

9

Enhanced effectivity of an ALK5-inhibitor after cell-specific delivery to hepatic stellate cells in mice with liver injury.

van Beuge MM, Prakash J, Lacombe M, Post E, Reker-Smit C, Beljaars L, Poelstra K. van Beuge MM, et al. PLoS One. 2013;8(2):e56442. doi: 10.1371/journal.pone.0056442. Epub 2013 Feb 18. PLoS One. 2013. PMID: 23441194 Free PMC article.

10

Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.

van Beuge MM, Prakash J, Lacombe M, Gosens R, Post E, Reker-Smit C, Beljaars L, Poelstra K. van Beuge MM, et al. J Pharmacol Exp Ther. 2011 Jun;337(3):628-35. doi: 10.1124/jpet.111.179143. Epub 2011 Mar 7. J Pharmacol Exp Ther. 2011. PMID: 21383021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page